Promotional graphic with two images in hexagons. One showing pharmaceutical drugs and the other image showing a computer with CCDC software containing crystal structures on screen.

🙌We’re excited to be part of CMAC Open Days 2026!

We’ll be connecting with leaders from academia & industry, meeting research partners, and exploring how Industry 5.0 technologies are shaping the future of medicines manufacturing.

ccdc-info.com/4sk7DTe

#MedicinesManufacturing #CrystalEngineering

Promotional graphic with a laptop showing the Lattice web platform homepage on screen.

Don’t miss this week's webinar, which explores a data‑driven approach to boosting productivity and model development, using the CCDC web platform to enable collaboration while protecting proprietary data.

🔗 ccdc-info.com/3NTBulQ

#Pharma #MedicinesManufacturing #CompChemSky

💊 @md-catapult.bsky.social continues work on a cross-Catapult collaboration with @cgtcatapult.bsky.social and @hvmcatapult.bsky.social @ukcpi.bsky.social to support SMEs in #MedicinesManufacturing.

UK's VR-powered medicine maker scheme delivers first results A UK initiative to train a new generation of workers in medicines manufacturing has been taken up by around 1,200 people since it started last year.

#medicinesmanufacturing #pharmaceuticalmanufacturing #MedicinesManufacturingIndustryPartnership #MMIP #VRpoweredmedicine #Resilienceprogramme #virtualreality #mixedreality #bigpharma #MSD #AstraZeneca #EliLilly #pharmaceuticalpricing #NHS #ABPI #RandD #clinicaltrials
zurl.co/kOQr6

UK's VR-powered medicine maker scheme delivers first results A UK initiative to train a new generation of workers in medicines manufacturing has been taken up by around 1,200 people since it started last year.

A #UK government-backed #initiative to train a new generation of #skilledworkers in #medicinesmanufacturing has been taken up by around 1,200 people since it started 18 months ago.

pharmaphorum.com/news/uks-vr-...

MHRA publishes ‘world first’ decentralised manufacturing guidance Guidance on decentralised, or point-of care (POC), medicines manufacture has been published by the Medicines and Healthcare Regulatory Agency (MHRA), in what the body said is a world first. In its…

Guidance on decentralised, or point-of care, medicines manufacture has been published by the Medicines and Healthcare Regulatory Agency, in what the body said is a world first
#ukpharmacy #medicinesmanufacturing

Shaping the future of cell and gene therapy manufacturing at Advanced Therapies Europe 2024 - Cell and Gene Therapy

@cgtcatapult.bsky.social is working to address the challenge of sustainability in #MedicinesManufacturing, exploring ways to advance sustainable practices through focusing on waste reduction, energy efficiency and material reuse ♻️

🔗 loom.ly/XOEVEqs

Great to see #LifeSciences and #Biotech companies driving innovation in #MedicinesManufacturing to make it more efficient and sustainable 🌱 ➡️ ow.ly/zOCR50VqjRm

In this case study, @cytiva.bsky.social explores practical solutions to reduce the carbon footprint in monoclonal antibody manufacturing.